FAMOTIDINE
As listed in the register: FAMOTIDINE
40 mg · tablet
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Famotidine
- Made by
- Sivem Pharmaceuticals Ulc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (famotidine). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Famotidine is a competitive inhibitor of histamine-2 (H 2 ) receptors.
The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion.
Famotidine is eliminated by renal (65 to 70%) and metabolic (30 to 35%) routes.
Bioavailability may be slightly increased by food, or slightly decreased by antacids; however, these effects are of no clinical consequence.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-26
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (famotidine). It describes the substance, not this Bulgarian product — its uses and doses can differ.
- Famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (H 2 ) receptor antagonists.
- History of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other H 2 receptor antagonists.
The most common adverse reactions are: headache, dizziness, constipation, and diarrhea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States43 matching products
Bulgaria5 matching products
Spain5 matching products
Netherlands10 matching products
- Famotidine 40 mg Focus Care 40 mg · filmomhulde tablet
- Famotidine Aurobindo 40 mg 40 mg · filmomhulde tablet
- Famotidine Centrafarm 40 mg 40 mg · filmomhulde tablet
- Famotidine CF 40 mg 40 mg · filmomhulde tablet
- Famotidine Glenmark 40 mg 40 mg · filmomhulde tablet
- Famotidine Prolepha 40 mg 40 mg · filmomhulde tablet
- Famotidine Sandoz 40 mg 40 mg · filmomhulde tablet
- Famotidine Teva 40 mg 40 mg · filmomhulde tablet
Details
| Made by | Sivem Pharmaceuticals Ulc |
|---|---|
| Active substance | Famotidine |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 40 mg |
| Form | tablet |
| Classification | A02BA03 · Digestion, stomach, diabetes and nutrition |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02549115 |
| DPD drug code | 103799 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet4 products
20 mg2
20 mg · 2 companies
40 mg2
40 mg · 2 companies
- Sanis Health Inc
- Sivem Pharmaceuticals Ulc · this page
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.